Presentation TCT 2016 In This Case: Contrast Was an Alternative to Adenosine for Stenosis Interrogation Presenter: Javier Escaned, Habib Samady, William F. Fearon October 30, 2016
Presentation TCT 2016 In This Case: iFR Vessel Mapping Was Key to Identify the PCI Target Segment Presenter: Javier Escaned, Habib Samady, Hitoshi Matsuo October 30, 2016
Presentation TCT 2016 In This Case: FFR in Complex Multivessel PCI Was Key for Decision-making Presenter: Javier Escaned, Habib Samady, Keith G. Oldroyd October 30, 2016
Presentation ESC 2016 Drug-Eluting vs Bare Metal Stents in Saphenous Vein Grafts: The Prospective Randomized BASKET-SAVAGE Trial Presenter: Raban V. Jeger August 31, 2016
Presentation ESC 2016 “Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX Presenter: Deepak L. Bhatt August 31, 2016
Presentation ESC 2016 PRAGUE-18 Study: Randomized Comparison Of Ticagrelor Versus Prasugrel In STEMI Presenter: Zuzana Motovska August 30, 2016
Presentation ESC 2016 Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion (the EROSION study) Presenter: Ik-Kyung Jang August 30, 2016
Presentation ESC 2016 Edoxaban vs Enoxaparin-Warfarin in Subjects UndergoingCardioversion of Atrial Fibrillation Presenter: Andreas Goette August 30, 2016
Presentation ESC 2016 CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT) Presenter: John P. Greenwood August 29, 2016
Presentation ESC 2016 DOCTORS: Does Optical Coherence Tomography Optimise Results of Stenting? Presenter: Nicolas Meneveau August 29, 2016
Presentation ESC 2016 10-year outcomes of coronary artery bypass grafting vs medical therapy according to age: An update from the STICH trial Presenter: Eric Velazquez August 29, 2016
Presentation ESC 2016 Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Heart Failure Presenter: Javed Butler August 28, 2016
Presentation ESC 2016 NIPPON Randomized Study: 6 Months vs 18 Months Dual Antiplatelet Treatment For Patients Underwent Bioabsorbable Polymer And Abluminal Coated DES Deployment Presenter: Masato Nakamura August 28, 2016
Presentation ESC 2016 ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications Presenter: Gilles Montalescot August 28, 2016
Presentation ESC 2016 Feasibility and Safety of Direct Catheter - Based Thrombectomy in the Treatment of Acute Ischemic Stroke: Prospective Registry PRAGUE-16 Presenter: Petr Widimsky August 27, 2016
Presentation ESC 2016 ESC-EAS Guidelines for the Management of Dyslipidaemias Presenter: Ian Graham August 27, 2016
Presentation ESC 2016 Cancer Treatments And Cardiovascular Toxicity Developed Under The Auspices Of The ESC Committee for Practice Guidelines Presenter: Patrizio Lancellotti August 27, 2016
Presentation TCT 2015 Intervention for Tricuspid Regurgitation: What Do the Guidelines Say? (ACC/AHA and ESC/EACTS) Presenter: Rebecca T. Hahn, Joachim Schofer, Alec S. Vahanian October 15, 2015
Presentation TCT 2015 Escalation Therapies and RV Dysfunction: New Opportunities Presenter: Tanveer Rab, Holger Thiele, Navin K. Kapur October 14, 2015
Presentation TCT 2015 Latest Innovations in ECMO and Escalation of Therapy Presenter: Valluvan Jeevanandam, Ulrich P. Jorde, Jonathan M. Hill October 14, 2015